| scholarly article | Q13442814 |
| P356 | DOI | 10.1183/09031936.05.00072504 |
| P698 | PubMed publication ID | 15863640 |
| P50 | author | Marc Humbert | Q33113039 |
| Agnes Noel | Q57323939 | ||
| P2093 | author name string | C Lafuma | |
| C Munaut | |||
| E Fadel | |||
| S Eddahibi | |||
| S Adnot | |||
| H Lepetit | |||
| E Frisdal | |||
| M-P D'Ortho | |||
| P433 | issue | 5 | |
| P921 | main subject | idiopathic pulmonary arterial hypertension | Q5832696 |
| P304 | page(s) | 834-842 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | European Respiratory Journal | Q12257435 |
| P1476 | title | Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension | |
| P478 | volume | 25 |
| Q37410202 | A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents |
| Q42702771 | A translational preclinical model of interstitial pulmonary fibrosis and pulmonary hypertension: mechanistic pathways driving disease pathophysiology |
| Q36695298 | Activation of AMPK Prevents Monocrotaline-Induced Extracellular Matrix Remodeling of Pulmonary Artery |
| Q44706636 | Activation of proMMP-2 by U46619 occurs via involvement of p(38)MAPK-NFκB-MT1MMP signaling pathway in pulmonary artery smooth muscle cells |
| Q37256775 | Baicalin Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension to Improve Hypoxic Cor Pulmonale by Reducing the Activity of the p38 MAPK Signaling Pathway and MMP-9. |
| Q53471967 | CPU86017 and its isomers improve hypoxic pulmonary hypertension by attenuating increased ETA receptor expression and extracellular matrix accumulation. |
| Q35029120 | Cell-specific dual role of caveolin-1 in pulmonary hypertension |
| Q34269881 | Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension |
| Q35595010 | Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients |
| Q35053507 | Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertension |
| Q33859158 | Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats |
| Q36535637 | Gene expression analysis of a murine model with pulmonary vascular remodeling compared to end-stage IPAH lungs |
| Q34648773 | Gene expressions of nitric oxide synthase and matrix metalloproteinase-2 in monocrotaline-induced pulmonary hypertension in rats after bosentan treatment |
| Q43240666 | Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells |
| Q33920050 | Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension |
| Q33764751 | Hypoxia-induced mitogenic factor (FIZZ1/RELMα) induces endothelial cell apoptosis and subsequent interleukin-4-dependent pulmonary hypertension |
| Q36541868 | Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) in chronic hypoxia- and antigen-mediated pulmonary vascular remodeling |
| Q38461691 | Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea |
| Q33895831 | Inhaled PLGA particles of prostaglandin E₁ ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency |
| Q50212129 | Inhibition of pro-/active MMP-2 by green tea catechins and prediction of their interaction by molecular docking studies. |
| Q92545496 | Inhibitory effects of formononetin on the monocrotaline‑induced pulmonary arterial hypertension in rats |
| Q36787202 | Investigation of MMP-2 and MMP-9 activities in canine sera with dilated cardiomyopathy |
| Q46253709 | Involvement of calcium-sensing receptors in hypoxia-induced vascular remodeling and pulmonary hypertension by promoting phenotypic modulation of small pulmonary arteries |
| Q35014605 | Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats |
| Q83538631 | Involvement of matrix metalloproteinase-2 in medial hypertrophy of pulmonary arterioles in broiler chickens with pulmonary arterial hypertension |
| Q41888223 | Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q37892336 | Mechanisms of disease: pulmonary arterial hypertension. |
| Q79984435 | Metalloproteinase-9 in circulating monocytes in pulmonary hypertension |
| Q27009717 | Microvessel mechanobiology in pulmonary arterial hypertension: cause and effect |
| Q39124068 | NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II |
| Q34061821 | Novel mechanisms of sildenafil in pulmonary hypertension involving cytokines/chemokines, MAP kinases and Akt. |
| Q37689190 | PPARgamma as a potential therapeutic target in pulmonary hypertension |
| Q56388717 | Pathology of pulmonary hypertension |
| Q25255769 | Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells |
| Q38721118 | Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study. |
| Q35541250 | Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells |
| Q90727399 | Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension |
| Q92924608 | Pulmonary Hypertension Remodels the Genomic Fabrics of Major Functional Pathways |
| Q28395110 | Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica |
| Q38327916 | Pulmonary hypertension caused by pulmonary venous hypertension |
| Q37801516 | Regulation of the Pulmonary Circulation in the Fetus and Newborn |
| Q59336693 | Role of SOD3 in silica-related lung fibrosis and pulmonary vascular remodeling |
| Q36539476 | Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension |
| Q38112038 | Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension |
| Q82596361 | Suppression of tissue inhibitors of metalloproteinases may reverse severe pulmonary arterial hypertension |
| Q37100777 | Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice |
| Q37100760 | Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in mice |
| Q25255715 | Upregulated genes in sporadic, idiopathic pulmonary arterial hypertension |
| Q51082124 | Urokinase-type plasminogen activator deficiency (uPA-KO) prevented carotid artery ligation-induced vascular remodeling in mice. |
| Q33748607 | Vitamin D induces increased systolic arterial pressure via vascular reactivity and mechanical properties |
Search more.